Clene (CLNN)
Develops CNM-Au8, an investigational oral therapy for ALS and multiple sclerosis.
$4.51
vs last close−0.03 (−0.58%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 51 days
EPS estimate
−$0.46
Revenue estimate
$70.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.67−$0.09−$0.78−$0.85−$0.93−$0.69−$1.08Pending
Estimate−$1.21−$0.95−$0.49−$0.60−$0.74−$0.50−$0.37−$0.46
Surprise−38.0%+90.5%−59.2%−41.7%−25.7%−38.0%−193.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$91.0K$81.0K$27.0K$15.0K$77.0K$15.0K$90.0KPending
Estimate$138.3K$75.7K$65.4K$64.3K$26.0K$50.8K$61.0K$70.0K
Surprise−34.2%+7.0%−58.7%−76.7%+196.2%−70.4%+47.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.16 | — | — |
| Sep 2028 | −$0.14 | — | — |
| Jun 2028 | −$0.13 | — | — |
| Mar 2028 | −$0.14 | — | — |
| Dec 2027 | $0.27 | — | — |
| Sep 2027 | −$0.81 | — | — |
| Jun 2027 | −$0.85 | — | — |
| Mar 2027 | −$0.39 | — | — |
| Dec 2026 | −$0.27 | — | — |
| Nov 2026 | −$0.46 | — | — |
| Aug 2026 | −$0.37 | −$1.08 | −193.5% |
| May 2026 | −$0.50 | −$0.69 | −38.0% |
| Mar 2026 | −$0.74 | −$0.93 | −25.7% |
| Nov 2025 | −$0.60 | −$0.85 | −41.7% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.16 | — | — | $49.3K | — | — | — |
| Sep 2028 | −$0.14 | — | — | $52.4K | — | — | — |
| Jun 2028 | −$0.13 | — | — | $55.6K | — | — | — |
| Mar 2028 | −$0.14 | — | — | $59.1K | — | — | — |
| Dec 2027 | $0.27 | — | — | $24.5M | — | — | — |
| Sep 2027 | −$0.81 | — | — | $11.4M | — | — | — |
| Jun 2027 | −$0.85 | — | — | $50.0K | — | — | — |
| Mar 2027 | −$0.39 | — | — | $14.0K | — | — | — |
| Dec 2026 | −$0.27 | — | — | $80.0K | — | — | — |
| Nov 12, 2026 | −$0.46 | — | — | $70.0K | — | — | — |
| Aug 14, 2026 | −$0.37 | −$1.08 | −193.5% | $61.0K | $90.0K | +47.5% | −1.2% |
| May 14, 2026 | −$0.50 | −$0.69 | −38.0% | $50.8K | $15.0K | −70.4% | +8.5% |
| Mar 12, 2026 | −$0.74 | −$0.93 | −25.7% | $26.0K | $77.0K | +196.2% | +6.1% |
| Nov 13, 2025 | −$0.60 | −$0.85 | −41.7% | $64.3K | $15.0K | −76.7% | −22.4% |
| Aug 14, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 13, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 14, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 11, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 29, 2021 | |||||||
| Dec 18, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |